Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice.


Inflammatory bowel disease (IBD) is prevalent in industrialized countries, but rare in less-developed countries. Helminths, common in less-developed countries, may induce immunoregulatory circuits protective against IBD. IL-10(-/-) mice given piroxicam develop severe and persistent colitis. Lamina propria mononuclear cells from colitic IL-10(-/-) mice released IFN-gamma and IL-12. The ongoing piroxicam-induced colitis could be partially blocked with anti-IL-12 monoclonal antibody suggesting that the inflammation was at least partly IL-12 dependent. Colonization of piroxicam-treated colitic IL-10(-/-) mice with Heligmosomoides polygyrus (an intestinal helminth) suppressed established inflammation and inhibited mucosal IL-12 and IFN-gamma production. H. polygyrus augmented mucosal IL-13, but not IL-4 or IL-5 production. Transfer of mesenteric lymph node (MLN) T cells from IL-10(-/-) animals harboring H. polygyrus into colitic IL-10(-/-) recipients inhibited colitis. MLN T cells from worm-free mice did not. Foxp3 (scurfin) drives regulatory T cell function. H. polygyrus enhanced Foxp3 mRNA expression in MLN T cells that had regulatory activity. This suggests that H. polygyrus inhibits ongoing IL-10(-/-) colitis in part through blocking mucosal Th1 cytokine production. Resolution of inflammation is associated with increased IL-13 production and can be adoptively transferred by MLN T cells.

5 Figures and Tables

Citations per Year

1,761 Citations

Semantic Scholar estimates that this publication has 1,761 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Elliott2004HeligmosomoidesPI, title={Heligmosomoides polygyrus inhibits established colitis in IL-10-deficient mice.}, author={David E . Elliott and Tommy Setiawan and Ahmed Metwali and Arthur Blum and Joseph J. Urban and Joel V. Weinstock}, journal={European journal of immunology}, year={2004}, volume={34 10}, pages={2690-8} }